Home    Back

Device: in utero endoscopic correction of myelomeningocele ide - percutaneous technique    (DrugBank: -)

1 disease
IDDisease name (Link within this page)Number of trials
118Myelomeningocele1

118. Myelomeningocele    [ 9 clinical trials,   15 drugs,   (DrugBank: 7 drugs),   8 drug target genes,   11 drug target pathways]
Searched query = "Myelomeningocele", "Myeloschisis", "Myelocele", "Myelocystocele", "Syringomyelocele"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
1 / 9 trial found
No.TrialIDDate_
enrollment		Date_
registration		Public_titleScientific_titleConditionInterventionPrimary_
sponsor		Secondary_
sponsor		Recruitment_
Status		Inclusion_
agemin		Inclusion_
agemax		Inclusion_
gender		Target_
size		PhaseCountries
1NCT04362592
(ClinicalTrials.gov)		November 2, 201824/3/2020In-Utero Endoscopic Correction of Spina BifidaIn-Utero Endoscopic Correction of Spina Bifida: Laparotomy or PercutaneousNeural Tube Defects;Spina Bifida;MyelomeningoceleDevice: In Utero Endoscopic Correction of Myelomeningocele IDE - Percutaneous Technique;Device: In Utero Endoscopic Correction of Myelomeningocele IDE - Laparotomy/Uterine Exteriorization TechniqueUniversity of Southern CaliforniaNULLRecruiting18 Years52 YearsFemale33N/AUnited States